BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21860889)

  • 1. Nosocomial infection and characterization of extended-spectrum β-lactamases-producing Enterobacteriaceae in Northeast Brazil.
    Abreu AG; Marques SG; Monteiro-Neto V; Carvalho RM; Gonçalves AG
    Rev Soc Bras Med Trop; 2011; 44(4):441-6. PubMed ID: 21860889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
    Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
    Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.
    Empel J; Baraniak A; Literacka E; Mrówka A; Fiett J; Sadowy E; Hryniewicz W; Gniadkowski M;
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2449-54. PubMed ID: 18458126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME; Karageorgopoulos DE
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
    Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
    Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
    Bayraktar B; Toksoy B; Bulut E
    Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.
    Sanguinetti M; Posteraro B; Spanu T; Ciccaglione D; Romano L; Fiori B; Nicoletti G; Zanetti S; Fadda G
    J Clin Microbiol; 2003 Apr; 41(4):1463-8. PubMed ID: 12682131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and sensitivity profile of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary hospital in Southern Brazil.
    Rugini CL; Sobottka AM; Fuentefria DB
    Rev Soc Bras Med Trop; 2015; 48(6):692-8. PubMed ID: 26676493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.
    Tsakris A; Poulou A; Themeli-Digalaki K; Voulgari E; Pittaras T; Sofianou D; Pournaras S; Petropoulou D
    J Clin Microbiol; 2009 Nov; 47(11):3420-6. PubMed ID: 19726597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
    Sheng WH; Badal RE; Hsueh PR;
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-spectrum beta-lactamases among Enterobacteriaceae isolated in a public hospital in Brazil.
    Dropa M; Balsalobre LC; Lincopan N; Mamizuka EM; Murakami T; Cassettari VC; Franco F; Guida SM; Balabakis AJ; Passadore LF; Santos SR; Matté GR; Matté MH
    Rev Inst Med Trop Sao Paulo; 2009; 51(4):203-9. PubMed ID: 19739000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China.
    Munday CJ; Xiong J; Li C; Shen D; Hawkey PM
    Int J Antimicrob Agents; 2004 Feb; 23(2):175-80. PubMed ID: 15013044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of nosocomial CTX-M type beta-lactamase producing Enterobacteriaceae from a tertiary care hospital in south India.
    Jemima SA; Verghese S
    Indian J Med Microbiol; 2008; 26(4):365-8. PubMed ID: 18974492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of extended spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis in Okinawa prefecture, Japan.
    Nakama R; Shingaki A; Miyazato H; Higa R; Nagamoto C; Hamamoto K; Ueda S; Hachiman T; Touma Y; Miyagi K; Kawahara R; Toyosato T; Hirai I
    J Infect Chemother; 2016 May; 22(5):281-6. PubMed ID: 26898665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.